蓝海资本聚焦于医疗健康领域具有创新性的生物医药、医疗器械和医疗科技企业的成长期和并购投资。核心团队具有丰富的科研、产业和投资的国际化经验，投资成绩屡获业界殊荣。
自2015年成立以来，蓝海资本坚持深度投资和价值创造，为被投企业带来积极改变，为投资者创造长期价值。
蓝海资本于2022年初成为联合国支持的负责任投资原则（UN PRI）的签署机构，秉承资本向善的原则，推动责任投资，持续赋能投资企业可持续发展。
Blue Ocean Capital Group (“BOCG”) is a leading investment firm focusing on innovative biotech, medical device, and med-tech companies with growth and buyout strategies. Our award-winning team has vast industry experience and international insights.
Since founded in 2015, we have adopted value-driven approach and worked closely with entrepreneurs to bring meaningful impact on their businesses and ultimately create long-term value for our investors.
BOCG has become a signatory to the United Nations-supported Principles for Responsible Investment ("UN PRI") from the beginning of 2022. As a firm believer of Capital for Good, BOCG is devoted to responsible investment and empowers sustainable development of the portfolio companies.
创新型生物医药、医疗器械和医疗科技企业
Innovative biotech, medical device, med-tech companies
深度投资与价值创造并行，助力企业长远发展、实现共赢
Leverage our industry know-how to support portfolio companies’ long-term growth
我们的专业投资团队拥有丰富的行业和资本市场经验,国际化视野和优秀的投资业绩。我们致力赋能企业，与创业者一同缔造未来。
At the heart of our company is an expert-led team of investment professionals with significant industry and capital markets experience, international insights, and proven track record. We understand the importance of driving value in portfolio companies through operational expertise and improvement. Our dedicated team has deep industry knowledge to be valuable partners to our portfolio companies.
